文献速递妇科

患者对降低卵巢癌风险的输卵管切除术联合延迟卵巢切除术的观点:系统综述

Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature.
PubMed 文献 · Gynecol Oncol · 2023-04-26

该系统综述检索239条结果,纳入6篇文献,评估高风险患者对输卵管切除术联合延迟卵巢切除术(RRSDO)的接受度,范围为34%至71%。促进接受的因素包括避免手术绝经、保留生育功能、担心性功能障碍、乳腺癌家族史和避免激素替代治疗;限制因素包括肿瘤安全性、手术时机和手术并发症。

要点

  • RRSDO接受度在纳入研究中为34%至71%。
  • 促进接受因素:避免手术绝经、保留生育、担心性功能障碍、乳腺癌家族史、避免激素替代治疗。
  • 限制接受因素:肿瘤安全性、手术时机、手术并发症。

核心结论

  • 有限数据表明BRCA1/2携带者对RRSDO接受度较高,并揭示了促进和限制患者偏好的因素。

研究设计与样本

  • 系统综述,遵循PRISMA指南(PROSPERO注册号CRD42023400690),检索主要电子数据库,纳入6篇评估卵巢癌高风险患者对RRSO和RRSDO接受度及手术决策的研究。

主要发现

  • 检索得到239条结果,6篇文献符合纳入标准。
  • 所有研究均评估RRSDO接受度,范围为34%至71%。
  • 促进接受的因素包括避免手术绝经、保留生育功能、担心性功能障碍、乳腺癌家族史和避免激素替代治疗。
  • 限制接受的因素包括担心肿瘤安全性、手术时机和手术并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Increasing evidence suggests the fallopian tube as the site of origin of BRCA1/2-associated high-grade ovarian cancers. Several ongoing trials are evaluating salpingectomy with delayed oophorectomy (RRSDO) for ovarian cancer risk reduction and patients are beginning to ask their clinicians about this surgical option. This study sought to systematically review the available literature examining patient preferences regarding RRSDO and risk-reducing salpingo-oophorectomy (RRSO) to provide clinicians with an understanding of patient values, concerns, and priorities surrounding ovarian cancer risk-reducing surgery. METHODS: We conducted a systematic review in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PROSPERO No.: CRD42023400690). We searched key electronic databases to identify studies evaluating acceptance and surgical decision-making regarding RRSO and RRSDO among patients with an increased risk of ovarian cancer. RESULTS: The search yielded 239 results, among which six publications met the systematic review inclusion criteria. Acceptance of RRSDO was evaluated in all studies and ranged from 34% to 71%. Factors positively impacting patients' acceptance of RRSDO included: avoidance of surgical menopause, preservation of fertility, concerns about sexual dysfunction, family history of breast cancer, and avoidance of hormone replacement therapy. Factors limiting this acceptance reported by patients included concerns regarding oncologic safety, surgical timing, and surgical complications. CONCLUSION: To date, few studies have explored patient perspectives surrounding RRSDO. Collectively, the limited data available indicate a high level of acceptance among BRCA1/2 carriers, and provides insight regarding both facilitating and limiting factors associated with patient preferences to better equip clinicians in the counseling and support of their patients.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Perez L, Webster E, Bull L, et al. Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature. Gynecol Oncol. 2023. PMID: 37116391. doi:10.1016/j.ygyno.2023.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。